Evaluation of dose requirements for prolonged bivalirudin administration in patients with renal insufficiency and suspected heparin-induced thrombocytopenia.
about
Intravenous warfarin and heparin-induced thrombocytopenia: making the diagnosis, management, modern monitoring, and multidisciplinary care.Direct Thrombin Inhibitor Resistance and Possible Mechanisms.Development of a Predictive Nomogram for the Change in PT/INR Upon Discontinuation of Bivalirudin as a Bridge to Warfarin.Bivalirudin Medication Use Evaluation and Cost Savings Initiative.
P2860
Evaluation of dose requirements for prolonged bivalirudin administration in patients with renal insufficiency and suspected heparin-induced thrombocytopenia.
description
2012 nî lūn-bûn
@nan
2012 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2012 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
name
Evaluation of dose requirement ...... arin-induced thrombocytopenia.
@ast
Evaluation of dose requirement ...... arin-induced thrombocytopenia.
@en
type
label
Evaluation of dose requirement ...... arin-induced thrombocytopenia.
@ast
Evaluation of dose requirement ...... arin-induced thrombocytopenia.
@en
prefLabel
Evaluation of dose requirement ...... arin-induced thrombocytopenia.
@ast
Evaluation of dose requirement ...... arin-induced thrombocytopenia.
@en
P2093
P2860
P1476
Evaluation of dose requirement ...... arin-induced thrombocytopenia.
@en
P2093
James W Wisler
Jeffrey B Washam
Richard C Becker
P2860
P2888
P304
P356
10.1007/S11239-011-0677-3
P577
2012-04-01T00:00:00Z